Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234954 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
The results of our study have shown that concurrent chemoradiotherapy with a 120-h infusion of paclitaxel provides long-term local control and survival in patients with squamous cell carcinoma of the head and neck. Xerostomia, hypothyroidism, esophageal and pharyngeal complications, and subcutaneous fibrosis were common long-term toxicities; however, the vast majority of toxicities were grade 1 or 2.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Deborah M.D., John M.D., Anna M.D., Linda R.N., Paul S. Ph.D., Susan F. M.S.N., C.R.N.P., C.O.R.L.N., Theresa R.N., Ana D.D.S., Ph.D., Beth M.S., C.C.C.-S.L.P., A. Dimitrios M.D., Angelo M.D., John C. M.D., Laurie M.D., Sharon R.N., M.S., Carter M.D.,